1 results match your criteria: "and Universityof Pittsburgh Medical Center (UPMC) Children's Hospital of Pittsburgh[Affiliation]"

A porcine model of phenylketonuria generated by CRISPR/Cas9 genome editing.

JCI Insight

October 2020

Division of Medical Genetics, Department of Pediatrics, University of Pittsburgh School of Medicine, and Universityof Pittsburgh Medical Center (UPMC) Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania, USA.

Phenylalanine hydroxylase-deficient (PAH-deficient) phenylketonuria (PKU) results in systemic hyperphenylalaninemia, leading to neurotoxicity with severe developmental disabilities. Dietary phenylalanine (Phe) restriction prevents the most deleterious effects of hyperphenylalaninemia, but adherence to diet is poor in adult and adolescent patients, resulting in characteristic neurobehavioral phenotypes. Thus, an urgent need exists for new treatments.

View Article and Find Full Text PDF